Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas

被引:10
|
作者
Lee, Ming-Ching [1 ,2 ]
Buitrago, Daniel H. [1 ]
Kadota, Kyuichi [1 ,3 ]
Jones, David R. [1 ]
Adusumilli, Prasad S. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10065 USA
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA
关键词
IASLC; limited resection; lung adenocarcinoma; micropapillary; morphological subtypes; survival;
D O I
10.2217/LMT.14.15
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Micropapillary (MIP) histologic subtype included in the classification of lung adenocarcinomas (ADCs) is associated with both size-and stage-independent poor prognoses. MIP pattern in lung ADCs, even at small, early stages, correlates with high lymphovascular invasion, visceral pleural invasion and lymph node metastases. Recently, we reported that patients with a MIP component are at a higher risk of locoregional recurrence after limited resection. Identification of a MIP pattern is only possible with permanent pathologic sections; preoperative imaging, cytology or intraoperative frozen section specimens remain unreliable. The intermixed, heterogenous morphology of lung ADC presents a technical challenge in investigating the molecular biology of cells with MIP morphology. A comprehensive understanding of the biology of MIP morphology is vital for therapeutic interventions.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 50 条
  • [31] Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact
    Roesli, Christoph
    EXPERT REVIEW OF PROTEOMICS, 2015, 12 (01) : 5 - 8
  • [32] Recent pathology related advances in colorectal adenocarcinomas
    Goldstein, NS
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (05): : 446 - 450
  • [33] Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications
    Ruffner, Melanie A.
    Kennedy, Katie
    Cianferoni, Antonella
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (01) : 83 - 95
  • [34] Unusual RhD phenotypes -: recent advances and clinical implications
    Koermoeczi, G. F.
    BLOOD REVIEWS, 2007, 21 : S23 - S25
  • [35] Candida biofilm: Clinical implications of recent advances in research
    Press E.G.
    Shields R.K.
    Clancy C.J.
    Current Fungal Infection Reports, 2014, 8 (1) : 72 - 80
  • [36] CLINICAL IMPLICATIONS OF RECENT ADVANCES IN THE PHYSIOLOGY OF MOTILITY AND ABSORPTION
    ROWLANDS, EN
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1961, 54 (09): : 775 - 777
  • [37] Genetic testing for autism: recent advances and clinical implications
    Miller, David T.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (07) : 837 - 840
  • [38] Procedure-specific prognostic impact of micropapillary subtype may guide resection strategy in small-sized lung adenocarcinomas: a multicenter study
    Su, Hang
    Xie, Huikang
    Dai, Chenyang
    Zhao, Shengnan
    Xie, Dong
    She, Yunlang
    Ren, Yijiu
    Zhang, Lei
    Fan, Ziwen
    Chen, Donglai
    Jiang, Feng
    Liu, Jinshi
    Zhu, Quan
    Yao, Jie
    Ke, Honggang
    Wu, Chunyan
    Jiang, Gening
    Chen, Chang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [39] Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine
    Wright, Gavin M.
    Do, Hongdo
    Weiss, Jonathan
    Alam, Naveed Z.
    Rathi, Vivek
    Walkiewicz, Marzena
    John, Thomas
    Russell, Prudence A.
    Dobrovic, Alexander
    ONCOTARGET, 2014, 5 (08) : 2107 - 2115
  • [40] Micropapillary carcinoma has the worst prognosis among stage Ia lung adenocarcinomas
    Zombori, T.
    Urban, D.
    Nemedi, R.
    Tisziavicz, L.
    Furak, J.
    VIRCHOWS ARCHIV, 2016, 469 : S37 - S38